Company 3Legs Resources plc London S.E.
Equities
IM00B52P5P72
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- GBX | - |
2019 | SalvaRx Evaluates Takeover Opportunities | CI |
2019 | Salvarx Group plc Reports Earnings Results for the Half Year Ended June 30, 2019 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Denham Eke
DFI | Director of Finance/CFO | 73 | 19-01-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jim Mellon
CHM | Chairman | 68 | - |
Peter Redmond
BRD | Director/Board Member | 76 | - |
Gregory Bailey
FOU | Founder | 68 | 06-12-31 |
Denham Eke
DFI | Director of Finance/CFO | 73 | 19-01-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,699,642 | 7,460,186 ( 20.33 %) | 0 | 20.33 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+9.43% | 114B | |
+13.05% | 107B | |
-6.60% | 22.22B | |
-1.66% | 21.28B | |
-4.59% | 18.8B | |
-6.02% | 17.51B | |
-39.36% | 17.17B | |
+6.40% | 14.14B | |
+34.50% | 12.2B |
- Stock Market
- Equities
- SALV Stock
- Stock
- Company 3Legs Resources plc